| Multiple site collection [107] |
Invasive harvesting procedure [108] |
| Capacity of self-renewal [109] |
In vitro cell expansion difficulty [108] |
| Multilineage differentiation potential [109] |
Limited replication lifespan [110] |
| Easy and high yield of isolation cells [108] |
Require younger donors [111] |
| Supporting evidence, both in vitro and in vivo [107] |
|
| High osteogenic differentiation performance [110] |
|
| Potential for the treatment of several diseases [110] |
|
| Autologous, allogeneic, and xenologous are possible [110] |
|
| Free from ethical issues [110] |
|
| The primary source of stem cells [110] |
|
| Higher migration capacity [112] |
|
| Lower risk immune rejection [112] |
|
| Less susceptible to mutations [113] |
|
